Guatemala vs India: Previously treated cases tested for RR-/MDR-TB
Guatemala
85.0%
in 2024
India
86.0%
in 2024
Guatemala rank
100th
India rank
97th
Previously treated cases tested for RR-/MDR-TB over time
- Guatemala
- India
How they compare
India currently reports 86.0% against 85.0% in Guatemala, a difference of 1.0%.
The two have swapped places 4 times across 14 shared years of data; in 2007 it was India ahead.
Guatemala ranks 100th and India ranks 97th of 180 countries.
Across the 3 decades both report, Guatemala averaged higher in 2 and India in 1.
Head to head by decade
| Decade | Guatemala | India | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 39.3% | 0.6% | 38.7% | Guatemala |
| 2010s | 62.3% | 72.2% | 9.8% | India |
| 2020s | 91.2% | 84.2% | 7.0% | Guatemala |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Guatemala or India?
- India, at 86.0% against 85.0% in Guatemala as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Guatemala and India?
- 1.0%, with India ahead.
- How many years of comparable data are there for Guatemala and India?
- 14 years are reported by both, from 2007 to 2024.
- How do Guatemala and India rank globally for previously treated cases tested for rr-/mdr-tb?
- Guatemala ranks 100th and India ranks 97th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.